AtWork: The Relation Between Cognitive Functioning, Common Mental Disorders and Work Functioning
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorNorwegian University of Science and Technology
About this trial
Depression and anxiety affects levels of function across different levels like work, increasing levels of sick leave and as well as cognitive functioning. In the current study patients at risk of sick leave with depression and anxiety receive metacognitive therapy and work focus in an ordinary outpatient clinic. Impaired cognitive functioning may also be of importance in the return to work process and degree of sick leave. It is important to get a better understanding of how cognitive functioning is related to sick leave and if it predicts return to work, and if cognitive functioning is changed due to psychological treatment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
diagnosis of depression and/or anxiety,
at risk of sick leave
Disqualifiers
personality disorders cluster A or B,
ongoing substance abuse,
symptoms of psychosis,
acute suicidality,
Trial population
Patients referred with depression and/or anxiety disorders at risk of sick leave.
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
200 Participants
are grouped into 1 trial groupGroup A: Patients referred with depression and/or anxiety and at risk of sick leave
Trial outcomes
Primary outcomes
1
Patient Health Questionnaire-9 (PHQ-9)
Measure of depressive symptoms (PHQ-9) range 0-27 higher scores indicate higher degree of depressive symptoms
Time frame
Measured at pre-treatment and at therapy completion, an average of 10 weekly sessions, and at 6, 12 months follow-up2
Generalized Anxiety Disorder (GAD-7)
Anxiety symptoms (GAD-7) range 0-21 higher scores indicating higher degree of anxiety symptoms
Time frame
Measured at pre-treatment and at therapy completion, an average of 10 weekly sessions, and at 6, 12 months follow-up3
Changes in sick leave
Sick leave is collected from national register data measured in number of days of sick leave.
Time frame
Measured at pre-treatment and at therapy completion, an average of 10 weekly sessions, and at 6, 12 months follow-upSponsors and contacts
Click on the lead sponsor to view all of their trials.
Norwegian University of Science and Technology
Lead sponsor
Diakonhjemmet Hospital
Collaborator
The Research Council of Norway
Collaborator
Source ClinicalTrials.gov